KR900007939B1 - Novel microorganism for producing of glutamic acid - Google Patents
Novel microorganism for producing of glutamic acid Download PDFInfo
- Publication number
- KR900007939B1 KR900007939B1 KR1019880016534A KR880016534A KR900007939B1 KR 900007939 B1 KR900007939 B1 KR 900007939B1 KR 1019880016534 A KR1019880016534 A KR 1019880016534A KR 880016534 A KR880016534 A KR 880016534A KR 900007939 B1 KR900007939 B1 KR 900007939B1
- Authority
- KR
- South Korea
- Prior art keywords
- glutamic acid
- producing
- medium
- microorganism
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/14—Glutamic acid; Glutamine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/13—Brevibacterium
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/84—Brevibacterium
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
내용 없음.No content.
Description
본 발명은 글루타민산을 생산하는 미생물 및 이를 이용한 글루타민산의 제조방법에 관한 것으로, 좀더 구체적으로는 브레비박테리움 플라범 ATCC 14067의 변이주로서 페니실린계 항생제에 감수성이 높고 글루타민산을 탄소원 및 질소원으로 자화할 수 없는 특징이 있어 주성분이 포도당, 전분가수 분해물, 폐당밀인 배지에서 배양시 글루타민산을 고수율, 고농도로 생산할 수 있는 미생물에 관한 것이다.The present invention relates to a microorganism producing glutamic acid and a method for producing glutamic acid using the same, and more specifically, as a variant of Brevibacterium flavia ATCC 14067, it is highly susceptible to penicillin antibiotics and magnetizes glutamic acid as a carbon source and a nitrogen source. The present invention relates to a microorganism capable of producing high yield and high concentration of glutamic acid when cultured in a medium containing glucose, starch hydrolyzate and waste molasses as its main component.
종래 미생물을 이용하여 글루타민산을 생산하는 방법으로는 포도당, 전분가수분해물 등과 같은 당질내에 비오틴이 존재하지 않거나 극미량 존재하는 원료인 경우는 배지중에 비오틴을 제한적으로 첨가하거나, 고가인 포도당 및 전분가수분해물 대신에 비오틴이 과잉으로 존재하는 폐당밀 등을 원료로 사용하는 경우에는 계면활성제(양이온, 음이온, 비이온계) 또는 페니실린계 항생제를 첨가하여 글루타민산을 생산하는 방법이었다.Conventional methods for producing glutamic acid using microorganisms include biotin in the medium without glucose or starch hydrolyzate, or limited amounts of biotin in the medium, instead of expensive glucose and starch hydrolysates. In the case of using waste molasses containing excessive amounts of biotin as a raw material, glutamic acid was produced by adding a surfactant (cation, anion, nonionic) or penicillin antibiotic.
그러나 생산원가면에서 유리한 폐당밀(사탕수수당밀, 사탕무우당밀)속에는 비오틴이 과잉으로 존재하고 있음은 물론, 당밀의 종류 및 생산지등에 따라 비오틴의 함량에 차이가 나기 때문에 이를 사용할 경우, 비오틴의 농도에 따라서 페니실린계 항생제 또는 계면활성제의 첨가시기 및 양이 달라지고 이에 따라 생산성에도 영향을 미치는 문제점이 있었다.However, there is an excess of biotin in waste molasses (sugar cane molasses, sugar beet molasses), which is advantageous in terms of production cost. In addition, the concentration of biotin varies depending on the type of molasses and the place of production. In accordance with the addition time and amount of the penicillin antibiotic or surfactant is changed, thereby there was a problem affecting the productivity.
또한, 글루타민산 발효의 실제에 있어서 발효가 진행됨에 따라서 배지중에 글루타민산의 축적됨으로 인해 발효시작 전반부와 발효가 계속진행된 후반부의 구간별 당질소모에 대한 생산수율을 보면 후반부의 글루타민산 생산 수율이 현저하게 저하되는 것이 발견된다.In addition, in the actual fermentation of glutamic acid, as the fermentation proceeds, the yield of glutamic acid production in the latter part of the fermentation is markedly lowered by the accumulation of glutamic acid in the medium. Is found.
이러한 현상은 핵심효소인 글루타메이트 디하이드로게네이즈가 발효후반부가 되면 글루타민산에서 알파케토글루타레이트로의 반응을 진행시켜 기생성된 글루타민산의 소모됨에 의한 생산성의 저하로 판단된다.This phenomenon is considered to be a decrease in productivity due to the consumption of parasitic glutamic acid by the reaction of glutamic acid to alpha ketoglutarate when glutamate dihydrogenase, a key enzyme, is added in the latter part of fermentation.
따라서 본 발명자등은 상기 지적된 원인을 제거하고 어떠한 원료나 생산방법을 사용하더라도 항상 글루타민산을 고수율, 고농도로 생산 할 수 있는 미생물을 변이처리 결과 획득하여 본 발명을 완성하였다.Therefore, the present inventors have completed the present invention by removing the above-mentioned causes and obtaining a microorganism capable of producing glutamic acid at a high yield and high concentration at all times even if using any raw material or production method.
즉, 본 발명의 미생물은 세포벽합성능력이 부분적으로 결손되어 세포내에 생성된 글루타민산을 세포외로 용이하게 배출시켜서 세포내에 글루타민산이 고농도로 축적되거나 또는 세포내에 글루타민산의 과도하게 생성, 축적되므로해서 세포내에서 야기될 수 있는 생체내의 역기능을 제거키 위한 페니실린계 항생물질에 대한 높은 감수성 및/발효시에 있어서 세포외에서의 글루타민산의 농도가 높아짐에 따라 세포내에서도 글루타민산의 농도가 높아지게 되고 이런 환경이 조성되면 글루타메이트 디하이드로게네이즈가 역으로 작용하여 알파케토글루타레이트가 생성되거나 또는 상호 평행을 유지하므로써 글루타민산을 생성하지 못하는 역기능을 완화시키기 위해서 글루타민산을 탄소원 및 질소원으로 자화할 수 없는 특징을 가진 미생물이다.In other words, the microorganism of the present invention partially discharges the glutamic acid produced intracellularly due to partial deficiency of cell wall synthesis ability, so that glutamic acid is accumulated in the cell at a high concentration, or the glutamic acid is excessively produced and accumulated in the cell. Higher sensitivity to penicillin antibiotics and / or fermentation to remove possible dysfunction in vivo may result in higher concentrations of glutamic acid in the cell, resulting in higher concentrations of glutamic acid in the cell. Hydrogenase is a microorganism having a characteristic that can not magnetize glutamic acid as a carbon source and a nitrogen source in order to alleviate the dysfunction that does not produce glutamic acid by acting in reverse to produce alpha ketoglutarate or parallel to each other.
본 발명의 미생물(KFCC 10652)은 브레비 박테리움 플라범 ATCC 14067을 친주로하여 자외선조사, N-메틸-N'-니트로-N-니트로소-구아니딘(NTG)등의 변이 유발제로 통상적인 방법에 따라 처리한후 복합배지(폐당밀 0.5%, 포도당 2.0%, MgSO40.5g/l, 요소 0.1%, FeSO420mg/l, MnSO420mg/l, K2HPO40.5g/l, KH2PO41g/l, (NH4)2SO40.5%, 티아민염산염 200μg/l, 비오틴 μ20g/l, 한천 20g/l, pH 7.0)에 도말하여 코로니를 형성시킨 다음, 페니실린이 농도별로 첨가된 페니실린 첨가배지(육즙 1%, 펩톤 1%, 효모엑기스 0.5%, 포도당 1.0%, NaCl 0.25%, 한천 20g/l, 페니실린 0.01-0.4μ/ml까지 농도별로 첨가)로 이식하여 페니실린에 감수성이 높은 1차변이주를 얻은 후 이를 다시 상술한 변식제로 처리하여 복합배지에 도말하고 코로니를 형성시킨 다음, 탄소원 및 질소원으로 글루타민산만이 첨가된 글루타민산배지(글루타민산 나트륨염 10g/l, KH2PO41g/l, K2HPO40.5g/l, FeSO420mg/l, MnSO4, 20mg/l, MgSO40.05g/l, 티아민염산염 200μg/l, 비오틴 20μg/l, pH 7.0, 한천 20g/l)로 이식하여 생육하지 않은 변이주를 획득하고 이를 1988. 12. 6. 자로 한국종균협회에 기탁하였다(기 ; KFCC 10652).The microorganism of the present invention (KFCC 10652) is a conventional method as a mutagenesis agent such as ultraviolet irradiation, N-methyl-N'-nitro-N-nitroso-guanidine (NTG) with the Brevi bacterium flame ATCC 14067 as a parent Complex medium (waste molasses 0.5%, glucose 2.0%, MgSO 4 0.5g / l, urea 0.1%, FeSO 4 20mg / l, MnSO 4 20mg / l, K 2 HPO 4 0.5g / l, KH) 2 PO 4 1 g / l, (NH 4 ) 2 SO 4 0.5%, thiamine hydrochloride 200 μg / l, biotin μ20 g / l, agar 20 g / l, pH 7.0) to form a colony, and then penicillin is added by concentration Susceptibility to penicillin by transplanting into penicillin supplemented medium (1% broth, 1% peptone, 0.5% yeast extract, 1.0% glucose, 0.25% NaCl, 20g / l agar, added to 0.01-0.4μ / ml penicillin) After obtaining a high primary mutant strain, it was again treated with the above-described modifying agent to form a composite medium and to form a colony, and then glutamic acid with only glutamic acid as a carbon source and a nitrogen source. (Glutamic acid sodium salt, 10g / l, KH 2 PO 4 1g / l, K 2 HPO 4 0.5g / l, FeSO 4 20mg / l, MnSO 4, 20mg / l, MgSO 4 0.05g / l, thiamine hydrochloride 200μg / l , Biotin 20μg / l, pH 7.0, agar 20g / l) to obtain a non-growing mutant strain was deposited on June 6, 1988 to the Korean spawn association (Kee Ki KFCC 10652).
본 발명 미생물의 특성은 다음의 표에 기재된 바와 같다.The characteristics of the microorganism of the present invention are as described in the following table.
[표 1] 페니실린계 항생제에 대한 감수성 비교Table 1 Comparison of sensitivity to penicillin antibiotics
<주> + ; 생육, - ; 생육치못함, 30℃에서 48시간 배양.<Note> +; Growth,-; No growth, incubated at 30 ° C for 48 hours.
[표 2] 글루타민산 배지에서의 생육도 비교Table 2 Growth Comparison in Glutamic Acid Medium
<주> 글루타민산 배지 조성중 한천을 제외한 배지사용, 용량 500ml의 배양용 삼각플라스크에 사용배지 40ml를 넣고 살균후 균주를 식균하여 30℃에서 180rpm으로 72시간 진탕배양.<Note> Glutamic acid in the composition of the medium except agar, 40 ml of the medium used in a culture flask for the culture of 500ml capacity, and after sterilization, strains were incubated for 72 hours at 30 ℃ 180 rpm shaking culture.
다음의 실시예에서 본 발명을 좀더 구체적으로 설명한다.The present invention is explained in more detail in the following examples.
실시예 1Example 1
사용균주 ; 본 발명 미생물(KFCC 10652), ATCC 14067.Used strain; Microorganism of the Invention (KFCC 10652), ATCC 14067.
1차종배지 ; 폐당밀 0.5%, 포도당 9.0%, MgSO40.5g/l, 요소 0.1%, FeSO420mg/l, MnSO420mg/l, K2HPO40.5g/l, KH2PO41g/l, (NH4)2SO40.5%, 티아민염산염 200μg/l, 비오틴 20μg/1, pH 7.0.Primary species medium; Waste molasses 0.5%, glucose 9.0%, MgSO 4 0.5g / l, urea 0.1%, FeSO 4 20mg / l, MnSO 4 20mg / l, K 2 HPO 4 0.5g / l, KH 2 PO 4 1g / l, ( NH 4 ) 2 SO 4 0.5%, thiamine hydrochloride 200 μg / l, biotin 20 μg / 1, pH 7.0.
2차종배지 ; 폐당밀(전화당으로) 2.0%, 글루코오즈 1%, 콘스팁리커 3%, MgSO40.5g/l, 요소 0.2%, KH2PO41g/l, K2HPO40.5g/l, FeSO410mg/l, MnSO410mg/l, (NH4)2SO40.3%, 티아민염산염 200μg/l, 비오틴 100μg/l, pH 7.0.Secondary species medium; Lung molasses (as invert sugar) 2.0%, glucose 1%, corn steep liquor 3%, MgSO 4 0.5 g / l, urea 0.2%, KH 2 PO 4 1 g / l, K 2 HPO 4 0.5 g / l, FeSO 4 10 mg / l, MnSO 4 10 mg / l, (NH 4 ) 2 SO 4 0.3%, thiamine hydrochloride 200 μg / l, biotin 100 μg / l, pH 7.0.
발효배지 ; 폐당밀(전화당으로)8%, NH4H2PO40.15%, FeSO410mg/l, MeSO410mg/l, 콘스팁리커 3%, (NH4)2SO40.3%, 티아민염산염 200μg/l, pH 7.0.Fermentation medium; Waste molasses (as invert sugar) 8%, NH 4 H 2 PO 4 0.15%, FeSO 4 10 mg / l, MeSO 4 10 mg / l, corn steep liquor 3%, (NH 4 ) 2 SO 4 0.3%, thiamine hydrochloride 200 μg / l, pH 7.0.
1차종배양 ; 1차종배지를 40ml씩 250ml 용량의 진탕용 삼각플라스크에 넣고 살균후 사용균주를 식균하여 180rpm으로 30℃에서 20-24시간 진탕배양하였다.Primary species culture; The primary seed medium was placed in a 250 ml shake Erlenmeyer flask with 40 ml each, followed by sterilization of the strains used and shaken at 180 rpm for 20-24 hours at 30 ° C.
2차종배양 ; 2차종배지를 2.6리터 용량의 시험용발효조에 각 1.2리터씩 분주하고 121℃에서 10분간 살균, 냉각후 1차종배양에서 얻은 배양완료액을 5ml씩 접종하고 공기를 매분당 0.5-1.0리터 공급하면서 900rpm으로 30℃에서 12-25시간 배양하였다.Secondary species culture; Dispense 1.2 liters of each secondary medium into a 2.6 liter test fermenter, sterilize at 121 ° C for 10 minutes, inoculate 5 ml of the culture solution obtained in the primary culture after cooling, and supply 900-1.0 liters of air per minute. Incubated for 12-25 hours at 30 ℃.
발효방법 ; 상기 발효배지를 5리터 용량의 시험발효조에 1.8리터씩 분주하고 121℃에서 10분간 살균, 냉각하여 2차종배양액을 약 150ml씩 접종한후 공기를 매분당 1-2.5리터씩 공급하면서 900rpm, 30-37℃에서 배양하되 대수 증식기 초기부터 말기[OD5620.15-0.4(OD562×100)]사이에 페니실린을 0.3-1.2μ/ml 첨가하였다. 배양중 잔존 당농도가 0.5-1.5%가 되면 살균된 폐당밀 또는 폐당밀과 원당을 일정비율 혼합한 혼합당을 수시로 공급하였다. 추가한 당밀 또는 혼합당과 초기의 발효배지에 첨가된 당의 합계가 발효액량 대비 19%가 될때까지 계속 배양하였다. 배양중 pH는 암모니아수를 사용하여 7.8로 조절하였다. 배양완료후 글루타민산의 농도는 ATCC 14067이 96.6g/l, KFCC 10652이 140.8g/l이었다.Fermentation method; The fermentation broth was dispensed in 1.8 liter test fermentation tanks of 5 liters, sterilized and cooled at 121 ° C for 10 minutes, inoculated with approximately 150ml of secondary culture medium, and then supplied with 1-2.5 liters of air at 900rpm, 30- Incubation was carried out at 37 ° C., but 0.3-1.2 μ / ml of penicillin was added between the beginning and the end of the logarithmic growth phase [OD 562 0.15-0.4 (OD 562 × 100)]. When the residual sugar concentration in the culture reached 0.5-1.5%, sterilized waste molasses or mixed sugars containing a certain ratio of waste molasses and raw sugar were frequently supplied. Culture was continued until the sum of added molasses or mixed sugar and sugar added to the initial fermentation broth was 19% of the fermentation broth. The pH of the culture was adjusted to 7.8 using ammonia water. After incubation, the concentration of glutamic acid was 96.6 g / l for ATCC 14067 and 140.8 g / l for KFCC 10652.
상술한 바와 같이 본 발명의 미생물은 통상 글루타민산의 발효시에 사용되는 원료 즉, 포도당, 전분가수분해물(옥수수, 고구마, 타피호카 등의 전분), 폐당밀(사탕수수당밀, 사탕무우당밀)등을 사용할 수 있고 어떠한 원료를 사용하여라도 고농도, 고수율의 글루타민산을 생산할 수 있음은 물론, 글루타메이트 디하이드로 게네이즈와 역반응기작의 효소활성이 실활 또는 매우 약화되어 발효말기의 글루타민산 생산농도 및 생산수율을 향상시킬 수 있는 특징이 있는 것이다.As described above, the microorganism of the present invention is a raw material used in fermentation of glutamic acid, that is, glucose, starch hydrolyzate (starch such as corn, sweet potato, tapioca, etc.), waste molasses (sugar cane molasses, sugar beet molasses) and the like. It can be used to produce high concentration and high yield of glutamic acid by using any raw materials, as well as deactivation or very weakening of enzymatic activity of glutamate dehydrogenase and reverse reaction mechanism to improve glutamic acid production concentration and production yield at the end of fermentation. There is a characteristic that can be made.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1019880016534A KR900007939B1 (en) | 1988-12-12 | 1988-12-12 | Novel microorganism for producing of glutamic acid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1019880016534A KR900007939B1 (en) | 1988-12-12 | 1988-12-12 | Novel microorganism for producing of glutamic acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR900009957A KR900009957A (en) | 1990-07-06 |
| KR900007939B1 true KR900007939B1 (en) | 1990-10-23 |
Family
ID=19280069
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019880016534A Expired KR900007939B1 (en) | 1988-12-12 | 1988-12-12 | Novel microorganism for producing of glutamic acid |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR900007939B1 (en) |
-
1988
- 1988-12-12 KR KR1019880016534A patent/KR900007939B1/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| KR900009957A (en) | 1990-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3809611A (en) | Process for producing citric acid | |
| US3763008A (en) | Process for producing ribosides of heterocyclic organic bases by fermentation | |
| NO147927B (en) | AA device separates from two media located in each room on each side of an annular aperture between two parts that are movable relative to each other | |
| KR900007939B1 (en) | Novel microorganism for producing of glutamic acid | |
| KR900007940B1 (en) | Microorganisms Producing Glutamic Acid and Methods for Preparing Glutamic Acid Using the Same | |
| KR900007938B1 (en) | Novel microorganism for producing of glutamic acid | |
| US3087863A (en) | Amino acid synthesis | |
| KR900007948B1 (en) | Novel microorganism for producing of glutamic acid | |
| US3759789A (en) | Process for the microbial production of lysine and isoleucine | |
| KR900007946B1 (en) | Novel microorganism for producing of glutamic acid | |
| US3939042A (en) | Process for the production of L-glutamic acid | |
| KR900007947B1 (en) | Microorganisms Producing Glutamic Acid and Methods for Preparing Glutamic Acid Using the Same | |
| KR100264740B1 (en) | A microorganism producing glutamic acid and a producing method of the glutamic acid using the same | |
| US4729952A (en) | Process for producing L-glutamic acid by fermentation | |
| US4728610A (en) | Method for producing L-glutamic acid | |
| EP0469517A2 (en) | Process for producing L-glutamic acid | |
| US3920520A (en) | Fermentation process for producing optically active L-lysine | |
| KR900007944B1 (en) | Novel microorganism for producing of glutamic acid | |
| KR0134131B1 (en) | Microorganisms That Produce Sepharosporin C and Methods of Preparing Sepharosporin C Using the Same | |
| EP0567644B1 (en) | Process for producing l-alanine by fermentation | |
| KR100317901B1 (en) | A microorganism producing glutamic acid and a method for producing glutamic acid using said microorganism | |
| KR100264741B1 (en) | A microorganism producing glutamic acid and a producing method of the glutamic acid using the same | |
| KR900007945B1 (en) | Novel microorganism for producing of glutamic acid | |
| HU215248B (en) | Process for producing l-lysine | |
| KR900007942B1 (en) | Novel microorganism for producing of glutamin acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| PA0109 | Patent application |
St.27 status event code: A-0-1-A10-A12-nap-PA0109 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| R17-X000 | Change to representative recorded |
St.27 status event code: A-3-3-R10-R17-oth-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| G160 | Decision to publish patent application | ||
| PG1605 | Publication of application before grant of patent |
St.27 status event code: A-2-2-Q10-Q13-nap-PG1605 |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U11-oth-PR1002 Fee payment year number: 1 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 4 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 5 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 6 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 7 |
|
| FPAY | Annual fee payment |
Payment date: 19951207 Year of fee payment: 7 |
|
| LAPS | Lapse due to unpaid annual fee | ||
| PC1903 | Unpaid annual fee |
St.27 status event code: A-4-4-U10-U13-oth-PC1903 Not in force date: 19971024 Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE |
|
| PC1903 | Unpaid annual fee |
St.27 status event code: N-4-6-H10-H13-oth-PC1903 Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE Not in force date: 19971024 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-5-5-R10-R13-asn-PN2301 St.27 status event code: A-5-5-R10-R11-asn-PN2301 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-5-5-R10-R13-asn-PN2301 St.27 status event code: A-5-5-R10-R11-asn-PN2301 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-5-5-R10-R13-asn-PN2301 St.27 status event code: A-5-5-R10-R11-asn-PN2301 |
|
| P22-X000 | Classification modified |
St.27 status event code: A-4-4-P10-P22-nap-X000 |